published meta-analysis   sensitivity analysis   studies

adjuvant therapies in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias hospitalizationdetailed resultsDavoodi, 2020 0.85 [0.15; 4.62] 0.85[0.15; 4.62]Davoodi, 202010%54NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-06 17:38 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 547,608,830,831,829,901,680,595,828,681,1209,833,629,689,543,617,625,859,511,960 - roots T: 290